(Q45935288)
Statements
1 reference
At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy. (English)
1 reference
Ian Hamilton-Craig
1 reference
Karam Kostner
1 reference
David Colquhoun
1 reference
Stan Woodhouse
1 reference
7 July 2009
1 reference
18
1 reference
5
1 reference
343-346
1 reference